Meliva Kardiolita Hospital Vilnius

Transurethral resection of the prostate (TURP)

Hospital Stay

2 nights

Recovery Time

3-4 Days

Head of Urology

Dr. Jurijus Makevičius - Urologist, MD, PhD

Surgical procedure cutting away a section of the enlarged prostate.

Package Includes

Inpatient Stay: 2 Nights

Post-Op Care: 2 Days

Head of Urology: Dr. Jurijus Makevičius - Urologist, MD, PhD

Hospital overview

Meliva Kardiolita Hospital, located in the Lithuanian capital of Vilnius, is one of the leading private hospitals in the Baltic region and a trusted partner for My Medical Gateway patients seeking high-quality care in Europe. The hospital is accredited by the Joint Commission International (JCI), the globally recognised gold standard for patient safety, clinical governance and hospital management. This accreditation confirms that every procedure and policy at Kardiolita follows the same evidence-based standards required of major UK and Western European institutions.

Scale, facilities and management

Kardiolita operates within the Meliva Healthcare Group (formerly InMedica Group and Kardiolita Clinics), a national network that unites hospital and outpatient services under common clinical protocols and standards. Across Lithuania, Meliva employs over 600 staff and 500 doctors in 45 medical specialties and provides treatment for approximately 298,000 patients each year.
The Vilnius hospital is a medium-sized, multi-specialty centre with around 50 inpatient beds, a 10-bed intensive care unit and four fully equipped operating theatres capable of handling high-complexity cardiac, orthopaedic, and general surgical cases.
The hospital is directed by Andrius Kostogriz, responsible for overall governance and international partnerships. Under his leadership, Kardiolita has expanded its clinical research links with European institutions and maintained continuous JCI compliance since its original accreditation.

Medical specialists

Kardiolita’s medical team combines senior Lithuanian consultants with international training. Among its most experienced specialists are:
Prof. Giedrius Uždavinys, senior cardiac surgeon, who has performed thousands of coronary and valve procedures over five decades of practice;
Prof. Audrius Aidietis, interventional cardiologist and electrophysiology specialist;
Dr. Antanas Mickevičius MD PhD, Consultant bariatric and upper-gastrointestinal surgeon, who also practises in the UK NHS at the Royal Stoke University Hospital and performs roughly 200 bariatric procedures per year;
Dr. Justinas Vaičiulis, orthopaedic and trauma surgeon specialising in minimally invasive shoulder, knee and hip reconstruction;
Dr. Vaidotas Zabulis and Dr. Arūnas Grinkevičius, vascular surgeons recognised for expertise in endovenous laser therapy and arterial bypass techniques.

Name: Dr. Jurijus Makevičius - Urologist, MD, PhD

Title: Head of Specialty

Bio: Dr Jurijus Makevičius is a urologist with a strong academic and clinical background, specialising in the diagnosis and treatment of urological conditions with a particular focus on oncological urology and kidney function. His profile combines structured university training, international clinical exposure and active research involvement, positioning him as a modern, evidence-based specialist. He obtained his medical degree from Vilnius University between 2005 and 2011, before completing his residency in Urology at the same institution from 2011 to 2016. He went on to complete a PhD in Medicine, with research focused on kidney function following surgical treatment for cancer, underpinning his expertise in urological oncology and post-operative outcomes. Dr Makevičius has developed his clinical experience within leading Lithuanian institutions, including Vilnius University Hospital, the National Cancer Institute and Santaros Clinics, before joining Kardiolita Hospital (Meliva) in 2019. His work spans both general and specialised urology, with experience in managing complex cases within a university hospital environment. His professional development includes extensive international training across Europe, with clinical exposure in Italy, Sweden, Germany, the United Kingdom, Denmark, Spain and the Czech Republic. This breadth of experience supports the application of contemporary techniques and alignment with European standards of care. In addition to his clinical practice, Dr Makevičius is actively engaged in research, with scientific publications and conference participation in Lithuania and internationally. He is a member of the European Association of Urology and the Lithuanian Urological Society, and has been involved in academic initiatives from an early stage in his career. Within the MMG network, he represents a well-trained, research-active urologist offering patients confidence in both clinical quality and modern, evidence-based treatment approaches within a leading European healthcare environment.

Full profile

Dr. Jurijus Makevičius - Urologist, MD, PhD

Clinical services and technology

Kardiolita provides an integrated model of diagnosis, surgery and rehabilitation across cardiology, cardiac surgery, orthopaedics, bariatric surgery, general surgery, plastic and reconstructive surgery, urology and gynaecology.
Its diagnostic facilities include digital MRI and CT imaging, angiography suites and minimally invasive endoscopic systems. Surgical theatres are equipped for laparoscopic, arthroscopic and endovascular procedures, reducing recovery time and the need for prolonged hospitalisation.
A rehabilitation centre within the Meliva network provides physiotherapy, wound care and post-operative cardiac and musculoskeletal rehabilitation, enabling patients to complete recovery in a coordinated setting before returning home.

Performance and outcomes

Publicly available clinical data and independent international directories indicate strong performance across major disciplines:
Cardiac surgery: success rates exceeding 95 %, with coronary artery bypass grafting survival reported at 99 % for standard-risk patients.
Orthopaedics: average post-operative complication rate ≈ 3 %, with prosthetic joint lifespan of 17–18 years.
Bariatric surgery: complication rate 3–5 %, achieving 40–100 % excess-weight reduction within two years, depending on the procedure.
These statistics originate from audited hospital reporting and verified healthcare directories and demonstrate consistent performance levels comparable with Western European benchmarks.

Patient safety and quality assurance

Kardiolita’s infection-control programme meets JCI Category I infection-prevention standards, with continuous surveillance and antibiotic stewardship. All intensive-care patients are monitored by consultant anaesthetists 24 hours a day. Surgical pathways follow European Society of Anaesthesiology guidelines for thromboembolism prophylaxis and peri-operative antibiotic timing.

Coordination with MMG

For patients introduced to Kardiolita by MMG, all arrangements — from initial online consultation to admission, treatment and post-operative follow-up — are managed by an English-speaking international coordination team that are fluent in English. Pre-treatment assessments, laboratory tests and imaging can be organised within 48 hours of arrival, with most patients requiring hospital stays of two to five days, depending on procedure complexity.

Rehabilitation and continuing care

Rehabilitation begins immediately after surgery, guided by physiotherapists and specialist nurses. Cardiac patients enter structured exercise and monitoring programmes, while orthopaedic and bariatric patients receive detailed physiotherapy schedules and nutritional support. The Meliva network also provides tele-consultations and imaging reviews for patients once they return home, maintaining continuity of care.